מדד נזילות מהירה: Cryoport Corp (CYRX)

This chart of the quick ratio for Cryoport, Inc. (CYRX) on the GURU.Markets platform is fixed at 2.01. Cryoport, Inc. (CYRX) is expanding its cryogenic IT logistics through partnerships with cell therapy developers and mergers with manufacturing plants. The team relies on biomedical experts attracted by a unique technology stack. The business benefits from growing biopharmaceutical demand for ultra-low temperatures during transport.

As Cryoport, Inc. (CYRX) adapts to the normalization of demand within the cell therapy sector, working capital management becomes critically important. This ratio measures the company's ability to settle short-term debts using only cash and accounts receivable, completely ignoring low-liquidity inventories. This allows investors to assess real financial stability without accounting for warehouse risks. By analyzing the efficiency of covering current liabilities, one can judge whether the liquid reserve is sufficient for logistics automation.